DARLEEN NG-PEREZ: Open Payments
NPI 1487728309 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,371 in 131 payments from 27 companies in 2025. Trend: 2023 $2,359 · 2024 $4,463 · 2025 $3,371
Food & beverage: $3,317Education: $53
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 17 | $379 |
| Mallinckrodt Hospital Products Inc. | 16 | $360 |
| Vifor Pharma, Inc. | 9 | $358 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $308 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $238 |
| Otsuka America Pharmaceutical, Inc. | 7 | $210 |
| Novartis Pharmaceuticals Corporation | 8 | $209 |
| AstraZeneca Pharmaceuticals LP | 9 | $174 |
| Edwards Lifesciences Corporation | 1 | $163 |
| Vantive US Healthcare LLC | 4 | $116 |
Products named: TARPEYO, Veltassa, Kerendia, JARDIANCE, JYNARQUE, ACTHAR, FARXIGA, TERLIVAZ.
Industry payments across FL — which companies pay providers there.
